Pharma Journalist 8916 posts 0 comments

SMi Group Reports: Just under two weeks remaining until the 2nd Annual AI in Drug Delivery Conference takes place as a virtual conference on 15 and 16 March 2021. The conference is…
Read More...

EMA’s human medicines committee (CHMP) has started a rolling review of Sputnik V (Gam-COVID-Vac), a COVID-19 vaccine developed by Russia’s Gamaleya National Centre of Epidemiology and…
Read More...

ConserV Bioscience Limited a clinical-stage biotechnology company focused on developing vaccines that protect against endemic and emergent infectious diseases, and eTheRNA…
Read More...

Eisai Co., Ltd. announced that it has decided to assent to and support a project led by CA Medlynks Kenya, Ltd. (Headquarters: Nairobi), a subsidiary of the healthcare startup company…
Read More...

Amgen and Five Prime Therapeutics a clinical-stage biotechnology company focused on developing immuno-oncology and targeted cancer therapies, announced an agreement under which Amgen…
Read More...

ALX Oncology Holdings Inc. a clinical-stage immuno-oncology company developing therapies that block the CD47 checkpoint pathway, and Tallac Therapeutics, Inc. (“Tallac”), a privately…
Read More...

Vir Biotechnology, Inc. and GlaxoSmithKline plc provided an update on the VIR-7831 (GSK4182136) arm of the National Institutes of Health’s (NIH) Accelerating COVID-19 Therapeutic…
Read More...

The U.S. Food and Drug Administration (FDA) approved Pfizer Inc.’s (NYSE: PFE) supplemental New Drug Application (sNDA) for LORBRENA (lorlatinib), expanding the indication to include…
Read More...

Tempest Therapeutics, Inc., a clinical-stage oncology company developing first-in-class therapeutics that combine both precision and immune-mediated mechanisms, announced a clinical…
Read More...

Takeda Pharmaceutical Company Limited and Ovid Therapeutics Inc. a biopharmaceutical company committed to developing medicines that transform the lives of people with rare neurological…
Read More...